Fize Medica

Be'er Sheva, Israel Founded: 2014 • Age: 12 yrs
Devices for real-time urine monitoring are developed by Fize Medica.
Annual revenue - Latest available
Total funding $31.3M 5 rounds
Employees - Tracked headcount
Investors 4 Known backers
Products - Services tracked
Competitors 8 Brand Intelligence

About Fize Medica

Fize Medica is a company based in Be'er Sheva (Israel) founded in 2014 by Noam Levine. Fize Medica has raised $31.3 million across 5 funding rounds from investors including Rapha Capital Management, Valitas Ventures and eHealth Ventures. Fize Medica operates in a competitive market with competitors including Observe Medical, Serenno Medical, Curaco, iUFlow mHealth and Konee, among others.

  • Headquarter Be'er Sheva, Israel
  • Founders Noam Levine
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
Operational Areas
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Total Equity Funding
    $31.3 M (USD)

    in 5 rounds

  • Latest Funding Round
    $6 M (USD), Series A

    Mar 30, 2026

  • Investors
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

People of Fize Medica

Headcount 10-50
Employee Profiles 12
Board Members and Advisors 6
Employee Profiles
People
Eran Blankenstein
CFO
People
Dror Zerem
Chief Executive Officer
People
Noam Levine
CTO & Founder
People
Sima Faifman Kuchersky
VP, Product & Business Development

Unlock access to complete

Board Members and Advisors
people
Vivek K. Moitra
Scientific Advisor
people
Kevin Slawin
Chairman
people
Phillip D Levin
Scientific Advisor
people
Jonathan Halevy
Scientific Advisor

Unlock access to complete

Funding Insights of Fize Medica

Fize Medica has successfully raised a total of $31.3M across 5 strategic funding rounds. The most recent funding activity was a Series A round of $6 million completed in March 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investors in Fize Medica

Fize Medica has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Rapha Capital Management, Valitas Ventures and eHealth Ventures.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Rapha Capital Management is engaged in identifying and investing in biopharmaceutical companies.
Locked Locked Locked
Health-tech investments are facilitated by Valitas Ventures for global patients.
Locked Locked Locked
Early-stage digital health ventures are funded and supported.
Locked Locked Locked
Premium access

Investor details for Fize Medica

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Fize Medica

Investments
Premium access

Investment portfolio details for Fize Medica

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Fize Medica

Premium access

Detailed financials for Fize Medica

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Fize Medica Comparisons

Fize Medica Primary company
Description
Devices for real-time urine monitoring are developed by Fize...
Location
Be'er Sheva, Israel
Founded Year
2014
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Fize Medica

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Fize Medica

Fize Medica operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Observe Medical, Serenno Medical, Curaco, iUFlow mHealth and Konee, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Biofilm build-up is measured by a single-use digital urine meter.
Locked Locked Locked
Bedside urine output measuring device is developed for hospitalized patients.
Locked Locked Locked
Automatic excrement disposer for patients with limited mobility
Locked Locked Locked
Automated bladder monitoring is offered through an online platform.
Locked Locked Locked
Develops innovative diagnostic devices for the urinary system to enhance medical care.
Premium access

Detailed competitors of Fize Medica

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Fize Medica

Premium access

Complete news archive for Fize Medica

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Fize Medica

Fize Medica was founded in 2014 and raised its 1st funding round 6 years after it was founded.

Fize Medica is headquartered in Be'er Sheva, Israel.

Dror Zerem is the current CEO of Fize Medica.

Fize Medica is a funded company, having raised a total of $31.3M across 5 funding rounds to date.

Fize Medica was founded in 2014 as a developer of medical devices in the healthcare sector. Health status is monitored through urine analysis using a patented technology platform. Real-time urine production is tracked via an integrated module designed for accurate output measurement. The companys operations focus on creating solutions for clinical monitoring, with key leadership provided by its founder and CEO.

Fize Medica's top competitors include Observe Medical, iUFlow mHealth and Serenno Medical.

Fize Medica has 4 investors. Key investors include Rapha Capital Management, Valitas Ventures, eHealth Ventures, and Mendham Investment Group.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available